Search research articles
Contact Us
Filters
Showing results (101-110 of 205) with videos related to
Page
of 21
Sort By:
Cancer Treatment Reviews
|
November 2, 1999
Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer
L Pusztai, F J Esteva, M Cristofanilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel
L Zhang, Y K Lau, W Xia, et al.
Oncogene
|
October 5, 1995
Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu
D Yu, A Matin, W Xia, et al.
Nanotechnology
|
December 17, 2008
The fabrication and testing of electrospun silica nanofiber membranes for the detection of proteins
P-H Tsou, C-K Chou, Sm Saldana, et al.
The Journal of Hospital Infection
|
July 7, 2023
Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis
S-Y Lin, J-S Sun, M-C Hung, et al.
The Journal of Biological Chemistry
|
July 25, 1997
Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor
N Kiyokawa, E K Lee, D Karunagaran, et al.
The Journal of Biological Chemistry
|
November 5, 1997
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation
L Y Bourguignon, H Zhu, A Chu, et al.
Oncogene
|
May 16, 1998
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis
X F Le, S Vallian, Z M Mu, et al.
Oncogene
|
September 19, 1996
Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms
D Yu, B Liu, M Tan, et al.
Nature Cell Biology
|
November 21, 2001
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
B P Zhou, Y Liao, W Xia, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 205) with videos related to
Sort By:
Page
of 21
Cancer Treatment Reviews
|
November 2, 1999
Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer
L Pusztai, F J Esteva, M Cristofanilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel
L Zhang, Y K Lau, W Xia, et al.
Oncogene
|
October 5, 1995
Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu
D Yu, A Matin, W Xia, et al.
Nanotechnology
|
December 17, 2008
The fabrication and testing of electrospun silica nanofiber membranes for the detection of proteins
P-H Tsou, C-K Chou, Sm Saldana, et al.
The Journal of Hospital Infection
|
July 7, 2023
Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis
S-Y Lin, J-S Sun, M-C Hung, et al.
The Journal of Biological Chemistry
|
July 25, 1997
Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor
N Kiyokawa, E K Lee, D Karunagaran, et al.
The Journal of Biological Chemistry
|
November 5, 1997
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation
L Y Bourguignon, H Zhu, A Chu, et al.
Oncogene
|
May 16, 1998
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis
X F Le, S Vallian, Z M Mu, et al.
Oncogene
|
September 19, 1996
Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms
D Yu, B Liu, M Tan, et al.
Nature Cell Biology
|
November 21, 2001
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
B P Zhou, Y Liao, W Xia, et al.
Page
of 21